Committee on Development and Intellectual Property
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Is Software Still Patentable?
Is Software Still Patentable? The last four years have posed significant hurdles to software patents; nevertheless they continue to be filed and allowed. By James J. DeCarlo and George Zalepa | August 20, 2018 | The Recorder Over the past four years, decisions by the Supreme Court and Federal Circuit, as interpreted by the U.S. Patent and Trademark Office, have had a dramatic effect on software-related inventions. These decisions have focused primarily on what comprises patentable subject matter under 35 U.S.C. § 101 and whether a patent’s specification adequately supports the claims. While uncertainty still exists, recent court decisions, coupled with sound prosecution strategies, can be used to bolster a practitioner’s arguments before the USPTO and courts. In Alice v. CLS Bank (2014), the Supreme Court applied the now familiar “two-part test” first laid out in Mayo v. Prometheus (2012). Under this test, a claim is first analyzed to determine if it is “directed to” an abstract idea. If so, the claim is then analyzed to determine whether it recites “significantly more” than the identified abstract idea or just “routine and conventional” elements. This test was (and is) routinely applied to software claims, and the pendulum of patentability for software inventions post-Alice swung firmly towards ineligibility. Nearly all decisions by the Federal Circuit in the immediate aftermath of Alice found claims ineligible. Similarly, the USPTO’s allowance rate in software-related art units plummeted, and many allowed but not yet issued applications were withdrawn by the USPTO. While many cases are representative of this period, the decision in Electric Power Group v. -
Confusing Patent Eligibility
CONFUSING PATENT ELIGIBILITY DAVID 0. TAYLOR* INTRODUCTION ................................................. 158 I. CODIFYING PATENT ELIGIBILITY ....................... 164 A. The FirstPatent Statute ........................... 164 B. The Patent Statute Between 1793 and 1952................... 166 C. The Modern Patent Statute ................ ..... 170 D. Lessons About Eligibility Law ................... 174 II. UNRAVELING PATENT ELIGIBILITY. ........ ............. 178 A. Mayo Collaborative Servs. v. Prometheus Labs............ 178 B. Alice Corp. v. CLS Bank Int'l .......... .......... 184 III. UNDERLYING CONFUSION ........................... 186 A. The Requirements of Patentability.................................. 186 B. Claim Breadth............................ 188 1. The Supreme Court's Underlying Concerns............ 189 2. Existing Statutory Requirements Address the Concerns with Claim Breadth .............. 191 3. The Supreme Court Wrongly Rejected Use of Existing Statutory Requirements to Address Claim Breadth ..................................... 197 4. Even if § 101 Was Needed to Exclude Patenting of Natural Laws and Phenomena, A Simple Statutory Interpretation Would Do So .................... 212 C. Claim Abstractness ........................... 221 1. Problems with the Supreme Court's Test................221 2. Existing Statutory Requirements Address Abstractness, Yet the Supreme Court Has Not Even Addressed Them.............................. 223 IV. LACK OF ADMINISTRABILITY ....................... ....... 227 A. Whether a -
Patent Law: a Handbook for Congress
Patent Law: A Handbook for Congress September 16, 2020 Congressional Research Service https://crsreports.congress.gov R46525 SUMMARY R46525 Patent Law: A Handbook for Congress September 16, 2020 A patent gives its owner the exclusive right to make, use, import, sell, or offer for sale the invention covered by the patent. The patent system has long been viewed as important to Kevin T. Richards encouraging American innovation by providing an incentive for inventors to create. Without a Legislative Attorney patent system, the reasoning goes, there would be little incentive for invention because anyone could freely copy the inventor’s innovation. Congressional action in recent years has underscored the importance of the patent system, including a major revision to the patent laws in 2011 in the form of the Leahy-Smith America Invents Act. Congress has also demonstrated an interest in patents and pharmaceutical pricing; the types of inventions that may be patented (also referred to as “patentable subject matter”); and the potential impact of patents on a vaccine for COVID-19. As patent law continues to be an area of congressional interest, this report provides background and descriptions of several key patent law doctrines. The report first describes the various parts of a patent, including the specification (which describes the invention) and the claims (which set out the legal boundaries of the patent owner’s exclusive rights). Next, the report provides detail on the basic doctrines governing patentability, enforcement, and patent validity. For patentability, the report details the various requirements that must be met before a patent is allowed to issue. -
Horizon Book of Authorities
PATENTED MEDICINE PRICES REVIEW BOARD IN THE MATTER OF THE PATENT ACT R.S.C. 1985, C. P-4, AS AMENDED AND IN THE MATTER OF HORIZON PHARMA PLC (THE “RESPONDENT”) AND THE MEDICINE CYSTEAMINE BITARTRATE SOLD BY THE RESPONDENT UNDER THE TRADE NAME PROCYSBI® BOOK OF AUTHORITIES OF THE RESPONDENT (MOTION TO BIFURCATE, STRIKE EVIDENCE AND FOR THE INSPECTION AND PRODUCTION OF DOCUMENTS) Torys LLP 79 Wellington St. W., Suite 3000 Toronto ON M5K 1N2 Fax: 416.865.7380 Sheila R. Block Tel: 416.865.7319 [email protected] Andrew M. Shaughnessy Tel: 416.865.8171 [email protected] Rachael Saab Tel: 416.865.7676 [email protected] Stacey Reisman Tel: 416.865.7537 [email protected] Counsel to Respondent, Horizon Pharma PLC INDEX 1. Board Decision – Alexion Pharmaceuticals Inc. and the Medicine “Soliris” (September 20, 2017) 2. Alexion Pharmaceuticals Inc. v. Canada (Attorney General), 2019 FC 734 3. Celgene Corp. v. Canada (Attorney General), 2011 SCC 1 4. Board Decision – Alexion Pharmaceuticals Inc. and the Medicine “Soliris” (March 29, 2016) 5. Mayne Pharma (Canada) Inc. v. Aventis Pharma Inc., 2005 FCA 50 6. P.S. Partsource Inc. v. Canadian Tire Corp., 2001 FCA 8 7. Harrop (Litigation Guardian of) v. Harrop, 2010 ONCA 390 8. Merck & Co v. Canada (Minister of Health), 2003 FC 1511 9. Vancouver Airport Authority v. Commissioner of Competition, 2018 FCA 24 10. Merck & Co, Inc. v. Canada (Minister of Health), 2003 FC 1242 11. H-D Michigan Inc. v. Berrada, 2007 FC 995 12. Roger T. Hughes, Arthur Renaud & Trent Horne, Canadian Federal Courts Practice 2019 (Toronto: LexisNexis Canada Inc., 2019) 13. -
Compulsory Patent Licensing: Is It a Viable Solution in the United States Carol M
Michigan Telecommunications and Technology Law Review Volume 13 | Issue 2 2007 Compulsory Patent Licensing: Is It a Viable Solution in the United States Carol M. Nielsen Michael R. Samardzija University of Texas M.D. Anderson Cancer Center Follow this and additional works at: http://repository.law.umich.edu/mttlr Part of the Administrative Law Commons, and the Intellectual Property Law Commons Recommended Citation Carol M. Nielsen & Michael R. Samardzija, Compulsory Patent Licensing: Is It a Viable Solution in the United States, 13 Mich. Telecomm. & Tech. L. Rev. 509 (2007). Available at: http://repository.law.umich.edu/mttlr/vol13/iss2/9 This Symposium Article is brought to you for free and open access by the Journals at University of Michigan Law School Scholarship Repository. It has been accepted for inclusion in Michigan Telecommunications and Technology Law Review by an authorized editor of University of Michigan Law School Scholarship Repository. For more information, please contact [email protected]. COMPULSORY PATENT LICENSING: IS IT A VIABLE SOLUTION IN THE UNITED STATES? Carol M. Nielsen* Michael R. Samardzija** Cite as: Carol M. Nielsen and Michael R. Samardzija, Compulsory Patent Licensing: Is It a Viable Solution in the United States?, 13 MICH. TELECOMM. TECH. L. REV. 509 (2007), available at http://www.mttlr.org/volthirteen/nielsen&samardzija.pdf As technology continues to advance at a rapid pace, so do the number of patents that cover every aspect of making, using, and selling these innovations. In 1996, to compound the rapid change of technology, the U.S. Supreme Court affirmed that business methods are also patentable. -
Does Strict Territoriality Toll the End of Software Patents?
NOTES DOES STRICT TERRITORIALITY TOLL THE END OF SOFTWARE PATENTS? James Ernstmeyer* INTRODUCTION ............................................................................................. 1267 I. UNITED STATES PROTECTION FOR INTELLECTUAL PROPERTY RIGHTS IN SOFTWARE ........................................................................ 1269 A. Defining Software ...................................................................... 1269 B. Copyright Protection for Software ............................................ 1270 C. Patent Protection for Software .................................................. 1272 D. The Backlash Against Intellectual Property Rights in Software ..................................................................................... 1274 E. In re Bilski Turns Back the Clock .............................................. 1278 II. UNITED STATES SOFTWARE PATENTS IN CROSS-BORDER TRADE .... 1280 A. Global Economic Stakes in United States Software Patents ..... 1280 B. Congressional Protection of Patents in Cross-Border Trade ......................................................................................... 1281 C. Extraterritoriality Concerns in Applying § 271(f) to Software Patents ........................................................................ 1283 III. DO PATENTS PROTECT SOFTWARE? – WOULD COPYRIGHTS DO BETTER? ............................................................................................ 1287 A. Effects of the Microsoft v. AT&T Loophole .............................. 1287 B. Combining -
Chapter 2 Novelty and Inventive Step (Patent Act Article 29(1) and (2))
Note: When any ambiguity of interpretation is found in this provisional translation, the Japanese text shall prevail. Part III Chapter 2 Section 1 Novelty Chapter 2 Novelty and Inventive Step (Patent Act Article 29(1) and (2)) Section 1 Novelty 1. Overview Patent Act Article 29(1) provides as the unpatentable cases (i) inventions that were publicly known, (ii) inventions that were publicly worked (iii) inventions that were described in a distributed publication or made available to the public through electric telecommunication lines in Japan or a foreign country prior to the filing of the patent application. The same paragraph provides that a patent shall not be granted for these publicly known (Note) inventions (inventions lacking novelty, hereinafter referred to as "prior art” in this chapter.). The patent system is provided to grant an exclusive right to the patentee in exchange for disclosure of the invention. Therefore, the invention which deserves the patent should be novel. This paragraph is provided to achieve such a purpose. This Section describes the determination of novelty for an invention of the patent applications to be examined (hereinafter referred to as "the present application" in this Section.) (Notes) The term "publicly known" generally falls under Article 29(1)(i), or under the 29(1)(i) to (iii), hereinafter the latter is applied. 2. Determination of Novelty Inventions subject to determination of novelty are claimed inventions. The examiner determines whether the claimed invention has novelty by comparing the claimed inventions and the prior art cited for determining novelty and an inventive step (the cited prior art) to identify the differences between them. -
There Is No Such Thing As a Software Patent
There is no such thing as a software patent 1 Kim Rubin BSEE/CS 45 years technology experience 4 startups 100+ inventions Patent Agent Author Taught computer security Book shelf for patents 2 {picture of file cabinets here} 3 There is no such thing as a software patent 4 7.5 5 7.4 6 7.3 7 There is no such thing as a software patent. There is no such thing as a rubber patent. There is no such thing as a steel patent. There is no such thing as an electricity patent. 8 There is only ... a patent. 9 pro se en banc said embodiment 10 Czapinski v. St. Francis Hosp., Inc., 2000 WI 80, ¶ 19, 236 Wis. 2d 316, 613 N.W.2d 120. v. The Federal Food, Drug, and Cosmetic Act (FDCA), ch. 675, 52 Stat. 1040, as amended, 21 U.S.C. § 301 et seq., iSee 21 U.S.C. § 355(a); Eli Lilly & Co. v. Medtronic, Inc., 496 U.S. 661, 665—666, 674 (1990). 11 Article I, Section 8 8. “To promote the Progress of Science and useful Arts, by securing for limited Times to Inventors the exclusive Right to their Discoveries.” 12 Article I, Section 8 8. “To promote the Progress of Science and useful Arts, by securing for limited Times to Inventors the exclusive Right to their Discoveries … except for software.” 13 Jefferson, Congress, SCOTUS and MPEP 3. “The Act embodied Jefferson’s philosophy that ‘ingenuity should receive a liberal encouragement.’ 5 Writings of Thomas Jefferson, 75-76 Washington ed. 1871). -
Compulsory Licensing of Patented Inventions
Compulsory Licensing of Patented Inventions -name redacted- Visiting Scholar January 14, 2014 Congressional Research Service 7-.... www.crs.gov R43266 Compulsory Licensing of Patented Inventions Summary The term “compulsory license” refers to the grant of permission for an enterprise seeking to use another’s intellectual property without the consent of its proprietor. The grant of a compulsory patent license typically requires the sanction of a governmental entity and provides for compensation to the patent owner. Compulsory licenses in the patent system most often relate to pharmaceuticals and other inventions pertaining to public health, but they potentially apply to any patented invention. U.S. law allows for the issuance of compulsory licenses in a number of circumstances, and also allows for circumstances that are arguably akin to a compulsory license. The Atomic Energy Act, Clean Air Act, and Plant Variety Protection Act provide for compulsory licensing, although these provisions have been used infrequently at best. The Bayh-Dole Act offers the federal government “march-in rights,” although these have not been invoked in the three decades since that legislation has been enacted. 28 U.S.C. Section 1498 provides the U.S. government with broad ability to use inventions patented by others. Compulsory licenses have also been awarded as a remedy for antitrust violations. Finally, a court may decline to award an injunction in favor of a prevailing patent owner during infringement litigation, an outcome that some observers believe is akin to the grant of a compulsory license. A number of international agreements to which the United States and its trading partners are signatories, including the Paris Convention for the Protection of Industrial Property, World Trade Organization agreements, and certain free trade agreements, address compulsory licensing. -
Biopatents – a Threat to the Use and Conservation of Agrobiodiversity?
Advisory Board on Biodiversity and Genetic Resources at the Federal Ministry of Food, Agriculture and Consumer Protection (BMELV) Biopatents – A Threat to the Use and Conservation of Agrobiodiversity? Position Paper of the Advisory Board on Biodiversity and Genetic Resources at the Federal Ministry of Food, Agriculture and Consumer Protection (Translation of German original paper) May 2010 Lead author Dr. Peter H. Feindt, Cardiff University Members of the Advisory Board on Biodiversity and Genetic Resources at the BMELV (05/2010) Prof. Dr. Bärbel Gerowitt, University of Rostock (Chair) Dr. Peter H. Feindt, Cardiff University, Great Britain (Vice Chair) Dr. Frank Begemann, Federal Office for Agriculture and Food, Bonn Prof. Dr. Leo Dempfle, Technical University Muinch (TUM) Dr. Jan Engels, Bioversity International, Italy Dr. Lothar Frese, Julius Kuehn-Institute, Quedlinburg Prof. Dr. Hans-Rolf Gregorius, University of Goettingen Prof. Dr. Dr. h.c. Alois Heißenhuber, Technical University Muinch (TUM) Prof. Dr. Hans-Jörg Jacobsen, University of Hannover Dr. Alwin Janßen, Northwest German Forest Research Institute, Hann. Münden Dr. Ingrid Kissling-Näf, Federal Office for Professional Education and Technology, Switzerland Prof. Dr. Konrad Ott, University of Greifswald Prof. Dr. Lucia Reisch, Copenhagen Business School, Denmark Prof. em. Dr. Werner Steffens, Deutscher Fischerei-Verband e. V., (German Fisheries Association), Bonn Dr. Steffen Weigend, Friedrich-Loeffler-Institute, Federal Research Institute for Animal Health, Mariensee Citation of this paper Peter H. Feindt, Advisory Board on Biodiversity and Genetic Resources at the BMELV, 2010: Biopatents – A Threat to the Use and Conservation of Agrobiodiversity? Position Paper of the Advisory Board on Biodiversity and Genetic Resources at the Federal Ministry of Food, Agriculture and Consumer Protection (BMELV), 36 pp. -
Prior Art Searches in Software Patents – Issues Faced
Journal of Intellectual Property Rights Vol 23, November 2018, pp 243-249 Prior Art searches in Software Patents – Issues Faced Shabib Ahmed Shaikh, Alok Khode and Nishad Deshpande,† CSIR Unit for Research and Development of Information Products, Tapovan, S.No. 113 & 114, NCL Estate, Pashan Road, Pune - 411 008, Maharashtra, India Received: 15 November 2017; accepted: 24 November 2018 Prior-art-search is a critical activity carried out by intellectual property professionals. It is usually performed based on known source of literature to ascertain novelty in a said invention. Prior-art-searches are also carried out for invalidating a patent, knowing state of the art, freedom to operate studies etc. In many technological domains such as chemistry, mechanical etc., prior art search is easy as compared to domain such as software. In software domain, prior-art can prove to be a complex and tedious process relying heavily on non-patent literature which acts as a pointer to the current technological trends rather than patent documents. This paper tries to highlight the issues faced by patent professionals while performing prior-art search in the field of software patents. Keywords: Patents, Software patents, World Intellectual Property Organisation, Prior art, Search Issues A patent is a form of intellectual property. It provides The identification of the relevant prior art, comprising exclusionary rights granted by national IP office to an of existing patents and scientific or non-patent inventor or their assignee for a limited period of time literature is important as it has bearing on the quality in exchange for public disclosure of an invention. -
Google Inc. in Response to the PTO's Request for Comments on the Partnership for Enhancement of Quality of Software-Related Patents, Docket No
From: Suzanne Michel Sent: Monday, April 15, 2013 8:40 PM To: SoftwareRoundtable2013 Subject: Submission of Google Inc Please find attached the submission of Google Inc. in response to the PTO's request for comments on the partnership for enhancement of quality of software-related patents, Docket No. PTO-P-2012-0052. If possible, please send an acknowledgment of receipt of the submission. Thank you very much, Suzanne Michel -- Suzanne Michel Senior Patent Counsel, Google [email protected] 202 677- | | | 5398 Before the United States Patent and Trademark Office Alexandria, VA 22313 In re: ) ) Docket No. PTO-P-2012-0052 Request for Comments and Notice ) of Roundtable Events for ) Partnership for Enhancement of ) Quality of Software-Related ) Patents ) ) COMMENTS OF GOOGLE INC. Daryl L. Joseffer Suzanne Michel KING & SPALDING LLP GOOGLE INC. 1700 Pennsylvania Avenue, NW 1101 New York Avenue, N.W. Washington, DC 20006 Washington, DC 20005 (202) 737-0500 (650) 253-0000 Adam M. Conrad KING & SPALDING LLP 100 N Tryon Street, Suite 3900 Charlotte, NC 28202 (704) 503-2600 April 15, 2013 TABLE OF CONTENTS PART I: INTRODUCTION ...................................................................................................1 PART II: THE PTO SHOULD APPLY SECTION 112(F) TO MORE PATENTS THAT CLAIM SOFTWARE-IMPLEMENTED INVENTIONS ...........................3 A. Section 112(f) Permits The Use Of Functional Claim Elements Only When The Specification Discloses Sufficient Structure To Limit The Claim To The Applicant’s Actual Invention. ...............................3 1. As A Matter Of Policy And Precedent, Patent Law Has Never Permitted Pure Functional Claiming. .......................................3 2. Congress Enacted Section 112(f) To Permit Functional Claiming Accompanied By Sufficient Disclosures.